A high-resolution structure of ligand-free human glutamate carboxypeptidase II

Acta Crystallographica Section F: Structural Biology and Crystallization Communications

Volumn 63, Issue 3, 2007, Pages 150-153

  Barinka, Cyril ^a   Starkova, Jana ^b   Konvalinka, Jan ^b,c   Lubkowski, Jacek ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Folate hydrolases; Metallopeptidase; NAALADase; Prostate specific membrane antigens

Indexed keywords

GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II, HUMAN; LIGAND; MEMBRANE ANTIGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BINDING SITE; CHEMISTRY; CRYSTALLIZATION; DROSOPHILA; HUMAN; METABOLISM; PHYSIOLOGY; X RAY CRYSTALLOGRAPHY;

ANIMALS; ANTIGENS, SURFACE; BINDING SITES; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DROSOPHILA; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; LIGANDS; RECOMBINANT PROTEINS;

EID: 33947319738     PISSN: 17443091     EISSN: 17443091     Source Type: Journal    
DOI: 10.1107/S174430910700379X     Document Type: Article

References (18)

1. Barinka, C., Rinnova, M., Sacha, P., Rojas, C., Majer, P., Slusher, B. S. & Konvalinka, J. (2002). J. Neurochem. 80, 477-487.
2. Bostwick, D. G., Pacelli, A., Blute, M., Roche, P. & Murphy, G. P. (1998). Cancer, 82, 2256-2261.
3. Davis, M. I., Bennett, M. J., Thomas, L. M. & Bjorkman, P. J. (2005). Proc. Natl Acad. Sci. USA, 102, 5981-5986.
4. Gao, X., Porter, A. T., Grignon, D. J., Pontes, J. E. & Honn, K. V. (1997). Prostate, 31, 264-281.
5. Gulick, A. M., Horswill, A. R., Thoden, J. B., Escalante-Semerena, J. C. & Rayment, I. (2002). Acta Cryst. D58, 306-309.
6. Halsted, C. H., Ling, E. H., Luthi-Carter, R., Villanueva, J. A., Gardner, J. M. & Coyle, J. T. (1998). J. Biol. Chem. 273, 20417-20424.
7. Jones, T. A., Zou, J.-Y., Cowan, S. W. & Kjeldgaard, M. (1991). Acta Cryst. A47, 110-119.
8. Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. (1993). J. Appl. Cryst. 26, 283-291.
9. Mesters, J. R., Barinka, C., Li, W., Tsukamoto, T., Majer, P., Slusher, B. S., Konvalinka, J. & Hilgenfeld, R. (2006). EMBO J. 25, 1375-1384.
10. Murshudov, G. N., Vagin, A. A., Lebedev, A., Wilson, K. S. & Dodson, E. J. (1999). Acta Cryst. D55, 247-255.
11. Neale, J. H., Olszewski, R. T., Gehl, L. M., Wroblewska, B. & Bzdega, T. (2005). Trends Pharmacol. Sci. 26, 477-484.
12. Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307-326.
13. Pinto, J. T., Suffoletto, B. P., Berzin, T. M., Qiao, C. H., Lin, S., Tong, W. P., May, F., Mukherjee, B. & Heston, W. D. (1996). Clin. Cancer Res. 2, 1445-1451.
14. Rawlings, N. D. & Barrett, A. J. (1997). Biochim. Biophys. Acta, 1339, 247-252.
15. Robinson, M. B., Blakely, R. D., Couto, R. & Coyle, J. T. (1987). J. Biol. Chem. 262, 14498-14506.
16. Šácha, P., Zámečník, J., Bařinka, C., Hlouchová, K., Vícha, A., Mlč ochová, P., Hilgert, I., Eckschlager, T. & Konvalinka, J. (2007). Neuroscience, 144, 1361-1372.
17. Troyer, J. K., Beckett, M. L. & Wright, G. L. Jr (1995). Int. J. Cancer, 62, 552-558.
18. Zhou, J., Neale, J. H., Pomper, M. G. & Kozikowski, A. P. (2005). Nature Rev. Drug Discov. 4, 1015-1026.